Carmine Therapeutics, headquartered in Cambridge MA, is pioneering a new class of non-viral gene therapies based on red blood cell extracellular vesicles, combined with proprietary payloads.

Biotechnology

Carmine Therapeutics

John Robblee

Özge Gürsoy-Yüzügüllü,PhD

Qin Yu

Tenzin Gocha

The Carmine Therapeutics founding team has experience founding and working at various biopharma and technology companies. They also have experience in finance, which they gained from attending The Wharton School.

Founding Team

About

Team members

Other teams at Carmine Therapeutics

Leadership Team

Board of Directors